General

Multivalent gamma-delta T-cells: promising agents for the treatment of cancers 0:55
Multivalent gamma-delta T-cells: promising agents for the treatment of cancers
Jürgen Kuball • 10 Feb 2023
Rapid CAR-T manufacturing and challenges in this space 1:26
Rapid CAR-T manufacturing and challenges in this space
Nina Worel • 9 Feb 2023
An insight into novel third-generation TLR2 co-stimulatory CAR-T cells 1:13
An insight into novel third-generation TLR2 co-stimulatory CAR-T cells
Yasmin Nouri • 9 Feb 2023
Streamlining cell therapy manufacturing with CliniMACS Prodigy 2:08
Streamlining cell therapy manufacturing with CliniMACS Prodigy
Saskia Rösch • 6 Apr 2022
Implementing automation technology in the CGT space 1:28
Implementing automation technology in the CGT space
Saskia Rösch • 6 Apr 2022
Utilizing flow cytometry in CAR T-cell research 3:10
Utilizing flow cytometry in CAR T-cell research
Saskia Rösch • 6 Apr 2022
Applications of stem cell gene therapy beyond genetic diseases 1:04
Applications of stem cell gene therapy beyond genetic diseases
Luigi Naldini • 7 Apr 2022
Addressing challenges in using MSCs in cell therapies 3:00
Addressing challenges in using MSCs in cell therapies
Ross Macdonald • 19 Apr 2022
Generating iSPC-derived MSCs with the Cymerus™ Platform 2:34
Generating iSPC-derived MSCs with the Cymerus™ Platform
Ross Macdonald • 19 Apr 2022
Meeting the growing demand for gene therapy manufacturing 1:36
Meeting the growing demand for gene therapy manufacturing
John Maslowski • 27 Jan 2022
Direct detection and isolation of CAR cells from patient samples 1:27
Direct detection and isolation of CAR cells from patient samples
Saskia Rösch • 6 Apr 2022
Moving CAR T-cell therapies to earlier lines of therapy in multiple myeloma 2:30
Moving CAR T-cell therapies to earlier lines of therapy in multiple myeloma
Angela Krackhard • 6 Apr 2022
Engineering NK cell-based cancer treatments 1:22
Engineering NK cell-based cancer treatments
Juliane Mietz • 1 Apr 2022
Photoporation with polydopamine nanosensitizers for mRNA delivery to T cells 2:59
Photoporation with polydopamine nanosensitizers for mRNA delivery to T cells
Dominika Berdecka • 1 Apr 2022
The benefits of PiggyBac transposon-mediated CAR-T cell technology 2:37
The benefits of PiggyBac transposon-mediated CAR-T cell technology
Shigeki Yagyu • 8 Apr 2022
Developing individualized cancer therapies with neoantigen-specific TCRs 4:27
Developing individualized cancer therapies with neoantigen-specific TCRs
Angela Krackhard • 6 Apr 2022
The content of VJRegenMed is intended for healthcare professionals